vs
Side-by-side financial comparison of FOX FACTORY HOLDING CORP (FOXF) and Guardant Health, Inc. (GH). Click either name above to swap in a different company.
FOX FACTORY HOLDING CORP is the larger business by last-quarter revenue ($376.4M vs $281.3M, roughly 1.3× Guardant Health, Inc.). FOX FACTORY HOLDING CORP runs the higher net margin — -0.2% vs -45.7%, a 45.5% gap on every dollar of revenue. On growth, Guardant Health, Inc. posted the faster year-over-year revenue change (39.4% vs 4.8%). FOX FACTORY HOLDING CORP produced more free cash flow last quarter ($-2.5M vs $-54.2M). Over the past eight quarters, Guardant Health, Inc.'s revenue compounded faster (29.2% CAGR vs 6.4%).
Fox Factory Holding Corp. is an American company best known for their Fox Racing Shox brand of off-road racing suspension components.
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
FOXF vs GH — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $376.4M | $281.3M |
| Net Profit | $-634.0K | $-128.5M |
| Gross Margin | 30.4% | 64.6% |
| Operating Margin | 4.0% | -43.0% |
| Net Margin | -0.2% | -45.7% |
| Revenue YoY | 4.8% | 39.4% |
| Net Profit YoY | -113.3% | -15.8% |
| EPS (diluted) | $-0.02 | $-1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $376.4M | $281.3M | ||
| Q3 25 | $374.9M | $265.2M | ||
| Q2 25 | $355.0M | $232.1M | ||
| Q1 25 | $352.8M | $203.5M | ||
| Q4 24 | — | $201.8M | ||
| Q3 24 | $359.1M | $191.5M | ||
| Q2 24 | $348.5M | $177.2M | ||
| Q1 24 | $333.5M | $168.5M |
| Q4 25 | $-634.0K | $-128.5M | ||
| Q3 25 | $2.7M | $-92.7M | ||
| Q2 25 | $-259.7M | $-99.9M | ||
| Q1 25 | $-141.0K | $-95.2M | ||
| Q4 24 | — | $-111.0M | ||
| Q3 24 | $4.8M | $-107.8M | ||
| Q2 24 | $5.4M | $-102.6M | ||
| Q1 24 | $-3.5M | $-115.0M |
| Q4 25 | 30.4% | 64.6% | ||
| Q3 25 | 31.2% | 64.7% | ||
| Q2 25 | 30.9% | 65.0% | ||
| Q1 25 | 28.9% | 63.3% | ||
| Q4 24 | — | 61.6% | ||
| Q3 24 | 29.9% | 61.1% | ||
| Q2 24 | 31.8% | 59.1% | ||
| Q1 24 | 30.9% | 61.2% |
| Q4 25 | 4.0% | -43.0% | ||
| Q3 25 | 4.9% | -37.3% | ||
| Q2 25 | -70.6% | -45.9% | ||
| Q1 25 | 3.2% | -54.6% | ||
| Q4 24 | — | -62.4% | ||
| Q3 24 | 5.2% | -61.3% | ||
| Q2 24 | 5.3% | -56.8% | ||
| Q1 24 | 2.7% | -59.2% |
| Q4 25 | -0.2% | -45.7% | ||
| Q3 25 | 0.7% | -35.0% | ||
| Q2 25 | -73.1% | -43.0% | ||
| Q1 25 | -0.0% | -46.8% | ||
| Q4 24 | — | -55.0% | ||
| Q3 24 | 1.3% | -56.3% | ||
| Q2 24 | 1.6% | -57.9% | ||
| Q1 24 | -1.0% | -68.2% |
| Q4 25 | $-0.02 | $-1.01 | ||
| Q3 25 | $0.07 | $-0.74 | ||
| Q2 25 | $-6.23 | $-0.80 | ||
| Q1 25 | $0.00 | $-0.77 | ||
| Q4 24 | — | $-0.90 | ||
| Q3 24 | $0.11 | $-0.88 | ||
| Q2 24 | $0.13 | $-0.84 | ||
| Q1 24 | $-0.08 | $-0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $378.2M |
| Total DebtLower is stronger | $536.7M | $1.5B |
| Stockholders' EquityBook value | $956.0M | $-99.3M |
| Total Assets | $2.0B | $2.0B |
| Debt / EquityLower = less leverage | 0.56× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $378.2M | ||
| Q3 25 | — | $580.0M | ||
| Q2 25 | — | $629.1M | ||
| Q1 25 | $71.7M | $698.6M | ||
| Q4 24 | — | $525.5M | ||
| Q3 24 | — | $585.0M | ||
| Q2 24 | — | $933.7M | ||
| Q1 24 | — | $1.0B |
| Q4 25 | $536.7M | $1.5B | ||
| Q3 25 | $541.8M | $1.1B | ||
| Q2 25 | $546.9M | $1.1B | ||
| Q1 25 | $552.1M | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $558.4M | — | ||
| Q2 24 | $564.1M | — | ||
| Q1 24 | $370.4M | — |
| Q4 25 | $956.0M | $-99.3M | ||
| Q3 25 | $958.7M | $-354.5M | ||
| Q2 25 | $939.9M | $-305.5M | ||
| Q1 25 | $1.2B | $-250.8M | ||
| Q4 24 | — | $-139.6M | ||
| Q3 24 | $1.2B | $-60.1M | ||
| Q2 24 | $1.2B | $-1.6M | ||
| Q1 24 | $1.2B | $68.3M |
| Q4 25 | $2.0B | $2.0B | ||
| Q3 25 | $2.0B | $1.3B | ||
| Q2 25 | $1.9B | $1.3B | ||
| Q1 25 | $2.2B | $1.3B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $2.3B | $1.5B | ||
| Q2 24 | $2.3B | $1.6B | ||
| Q1 24 | $2.2B | $1.7B |
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.57× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.31× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.3M | $-26.4M |
| Free Cash FlowOCF − Capex | $-2.5M | $-54.2M |
| FCF MarginFCF / Revenue | -0.7% | -19.3% |
| Capex IntensityCapex / Revenue | 2.1% | 9.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $85.4M | $-233.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3M | $-26.4M | ||
| Q3 25 | $36.8M | $-35.4M | ||
| Q2 25 | $680.0K | $-60.3M | ||
| Q1 25 | $81.7M | $-62.7M | ||
| Q4 24 | — | $-64.5M | ||
| Q3 24 | $14.1M | $-51.1M | ||
| Q2 24 | $26.7M | $-94.0M | ||
| Q1 24 | $9.4M | $-30.3M |
| Q4 25 | $-2.5M | $-54.2M | ||
| Q3 25 | $24.6M | $-45.8M | ||
| Q2 25 | $-6.5M | $-65.9M | ||
| Q1 25 | $69.8M | $-67.1M | ||
| Q4 24 | — | $-83.4M | ||
| Q3 24 | $3.2M | $-55.3M | ||
| Q2 24 | $15.4M | $-99.1M | ||
| Q1 24 | $-555.0K | $-37.2M |
| Q4 25 | -0.7% | -19.3% | ||
| Q3 25 | 6.6% | -17.3% | ||
| Q2 25 | -1.8% | -28.4% | ||
| Q1 25 | 19.8% | -33.0% | ||
| Q4 24 | — | -41.3% | ||
| Q3 24 | 0.9% | -28.9% | ||
| Q2 24 | 4.4% | -55.9% | ||
| Q1 24 | -0.2% | -22.1% |
| Q4 25 | 2.1% | 9.9% | ||
| Q3 25 | 3.3% | 3.9% | ||
| Q2 25 | 2.0% | 2.4% | ||
| Q1 25 | 3.4% | 2.2% | ||
| Q4 24 | — | 9.4% | ||
| Q3 24 | 3.0% | 2.2% | ||
| Q2 24 | 3.2% | 2.9% | ||
| Q1 24 | 3.0% | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | 13.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.94× | — | ||
| Q2 24 | 4.94× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOXF
| Specialty Sports Group | $132.7M | 35% |
| Powered Vehicles Group | $125.9M | 33% |
| Aftermarket Applications Group | $117.8M | 31% |
GH
| Oncology | $189.9M | 68% |
| Biopharma Data | $54.0M | 19% |
| Screening | $35.1M | 12% |
| Licensing Other | $2.2M | 1% |
